Pneumococcal and influenza vaccines: a survey of knowledge and practice among UK paediatricians
Since January 2002 the Chief Medical Officer (CMO) in the UK has issued newsletters recommending limited use of the heptavalent pneumococcal conjugate vaccine (PCV) in children under 2 years old considered to be at high risk of pneumococcal infection. 1 In September 2006, the PCV was incorporated in...
Gespeichert in:
Veröffentlicht in: | Archives of disease in childhood 2007-08, Vol.92 (8), p.732-732 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Since January 2002 the Chief Medical Officer (CMO) in the UK has issued newsletters recommending limited use of the heptavalent pneumococcal conjugate vaccine (PCV) in children under 2 years old considered to be at high risk of pneumococcal infection. 1 In September 2006, the PCV was incorporated into the universal national immunisation schedule in the UK. 2 A survey of paediatricians in the North East of England was conducted to determine their knowledge and practice in respect of the CMO's recommendations. |
---|---|
ISSN: | 0003-9888 1468-2044 |
DOI: | 10.1136/adc.2007.121822 |